Levin, Fedor
Jelistratova, Irina
Betthauser, Tobey J.
Okonkwo, Ozioma
Johnson, Sterling C.
Teipel, Stefan J.
Grothe, Michel J. http://orcid.org/0000-0003-2600-9022
Funding for this research was provided by:
Alzheimer Forschung Initiative (#16037)
Miguel Servet program (CP19/00031)
Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (PI20/00613)
National Institutes of Health (AG027161, AG021155)
Alzheimer's Association (AARF-19-614533)
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
Article History
Received: 18 May 2021
Accepted: 11 October 2021
First Online: 21 October 2021
Declarations
:
: Study procedures within WRAP were approved by the Institutional Review Board of the University of Wisconsin. Each participant provided informed consent before participating in the study.
: Not applicable.
: SCJ is a scientific advisor to Roche Diagnostics and received grant funding from Cerveau Technologies. SJT participated in scientific advisory boards of Roche Pharma AG and MSD and received lecture fees from Roche, MSD, and Biogen. FL, IJ, TJB, OO, and MJG declare that they have no competing interests.